Cargando…

The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections

PURPOSE: Symptoms such as nausea, vomiting, tightness of the chest, bradycardia, and shoulder or abdominal discomfort, caused by vagotonia occurring during uterus manipulation, have concerned healthcare professionals for some time. Patients sometimes report these symptoms when undergoing spinal anes...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Shih-Hong, Chen, Shiou-Sheng, Chang, Ching-Tao, Huang, Chi-Hsiang, Fan, Shou-Zen, Chen, Li-Kuei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627848/
https://www.ncbi.nlm.nih.gov/pubmed/28746222
http://dx.doi.org/10.1097/MD.0000000000007624
_version_ 1783268780845039616
author Chen, Shih-Hong
Chen, Shiou-Sheng
Chang, Ching-Tao
Huang, Chi-Hsiang
Fan, Shou-Zen
Chen, Li-Kuei
author_facet Chen, Shih-Hong
Chen, Shiou-Sheng
Chang, Ching-Tao
Huang, Chi-Hsiang
Fan, Shou-Zen
Chen, Li-Kuei
author_sort Chen, Shih-Hong
collection PubMed
description PURPOSE: Symptoms such as nausea, vomiting, tightness of the chest, bradycardia, and shoulder or abdominal discomfort, caused by vagotonia occurring during uterus manipulation, have concerned healthcare professionals for some time. Patients sometimes report these symptoms when undergoing spinal anesthesia for cesarean sections (CSs). We designed a prospective, double-blind study to investigate the effectiveness of tenoxicam in preventing these symptoms of discomfort. METHODS: A total of 105 American Society of Anesthesiologists (ASA) class I-II nulliparous pregnant women, who were scheduled for a CS, were enrolled into this prospective, double-blind study. Spinal anesthesia was conducted to reach a peak dermatome level of no more than T3. The 100 patients were randomly divided into 2 groups having completed study course: Group T (N = 50) received a 20 mg dose of tenoxicam in 5 mL of normal saline (NS) immediately after skin incision and Group N (N = 50) only received 5 mL NS. The incidence and severity of the symptoms experienced by the patients were recorded by a nurse anesthetist who was blinded to the injection regimen the patients were receiving. A chi-square test was used for statistical analysis t test and P < .05 was defined as significant. RESULTS: The incidence and degree of severity of nausea and vomiting were same in both the groups. The incidence and degree of severity of bradycardia, nausea, vomiting, tightness of the chest, shoulder discomfort, and abdominal discomfort were lower in Group T than in Group N. CONCLUSION: Tenoxicam might theoretically block the parasympathetic vagus pathway and decrease the visceral pain or visceral-specific symptoms, alleviating the symptoms caused by vagotonia. However, the prophylactic effect of tenoxicam in reducing the incidence and severity of nausea and vomiting was not statistically significant. This could be because nausea and vomiting are not solely caused by vagotonia, but also by other mechanisms.
format Online
Article
Text
id pubmed-5627848
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-56278482017-10-12 The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections Chen, Shih-Hong Chen, Shiou-Sheng Chang, Ching-Tao Huang, Chi-Hsiang Fan, Shou-Zen Chen, Li-Kuei Medicine (Baltimore) 3300 PURPOSE: Symptoms such as nausea, vomiting, tightness of the chest, bradycardia, and shoulder or abdominal discomfort, caused by vagotonia occurring during uterus manipulation, have concerned healthcare professionals for some time. Patients sometimes report these symptoms when undergoing spinal anesthesia for cesarean sections (CSs). We designed a prospective, double-blind study to investigate the effectiveness of tenoxicam in preventing these symptoms of discomfort. METHODS: A total of 105 American Society of Anesthesiologists (ASA) class I-II nulliparous pregnant women, who were scheduled for a CS, were enrolled into this prospective, double-blind study. Spinal anesthesia was conducted to reach a peak dermatome level of no more than T3. The 100 patients were randomly divided into 2 groups having completed study course: Group T (N = 50) received a 20 mg dose of tenoxicam in 5 mL of normal saline (NS) immediately after skin incision and Group N (N = 50) only received 5 mL NS. The incidence and severity of the symptoms experienced by the patients were recorded by a nurse anesthetist who was blinded to the injection regimen the patients were receiving. A chi-square test was used for statistical analysis t test and P < .05 was defined as significant. RESULTS: The incidence and degree of severity of nausea and vomiting were same in both the groups. The incidence and degree of severity of bradycardia, nausea, vomiting, tightness of the chest, shoulder discomfort, and abdominal discomfort were lower in Group T than in Group N. CONCLUSION: Tenoxicam might theoretically block the parasympathetic vagus pathway and decrease the visceral pain or visceral-specific symptoms, alleviating the symptoms caused by vagotonia. However, the prophylactic effect of tenoxicam in reducing the incidence and severity of nausea and vomiting was not statistically significant. This could be because nausea and vomiting are not solely caused by vagotonia, but also by other mechanisms. Wolters Kluwer Health 2017-07-28 /pmc/articles/PMC5627848/ /pubmed/28746222 http://dx.doi.org/10.1097/MD.0000000000007624 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0
spellingShingle 3300
Chen, Shih-Hong
Chen, Shiou-Sheng
Chang, Ching-Tao
Huang, Chi-Hsiang
Fan, Shou-Zen
Chen, Li-Kuei
The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections
title The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections
title_full The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections
title_fullStr The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections
title_full_unstemmed The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections
title_short The use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections
title_sort use of tenoxicam to prevent symptoms of discomfort induced by vagotonia during uterus manipulation in cesarean sections
topic 3300
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627848/
https://www.ncbi.nlm.nih.gov/pubmed/28746222
http://dx.doi.org/10.1097/MD.0000000000007624
work_keys_str_mv AT chenshihhong theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT chenshiousheng theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT changchingtao theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT huangchihsiang theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT fanshouzen theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT chenlikuei theuseoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT chenshihhong useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT chenshiousheng useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT changchingtao useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT huangchihsiang useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT fanshouzen useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections
AT chenlikuei useoftenoxicamtopreventsymptomsofdiscomfortinducedbyvagotoniaduringuterusmanipulationincesareansections